Oxford University
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Scripta Therapeutics
14 Nov 2025
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.
Wild Bio
16 Oct 2025
Wild Bio secures £45m Series A led by the Ellison Institute of Technology to boost crop resilience by learning from wild species
Wild Bio applies AI and precision breeding to crop genetics, using insights from wild plant species to develop climate-resilient, higher-yield crop varieties for commercial agriculture.
Ultromics
31 Jul 2025
Ultromics raises £40m Series C led by L&G, Allegis Capital and Lightrock to expand AI heart failure diagnostics in the US
Ultromics develops AI software that analyses echocardiograms to help clinicians detect hard-to-diagnose heart failure conditions earlier, without requiring new hardware or changes to existing clinical workflows.
Oxford University
- 3(12 months)
- ox.ac.uk
- Update Information
More venture news
- 1 Jun 2026
EdifyEdify lands a £3m seed round led by Calculus to help quick service restaurants automate ordering, forecasting and back-of-house operations
SeedHospitality - 29 May 2026
CrimsonCrimson closes a £1.9m seed round led by Y Combinator to expand its case intelligence platform built for litigation and arbitration teams
SeedLegal - 28 May 2026
PercepticPerceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
SeedLife Sciences
